文献速递心境障碍

神经甾体与经前烦躁障碍

Neurosteroids and premenstrual dysphoric disorder.
PubMed 文献 · Br J Psychiatry · 2025-06-16

本文综述神经活性类固醇在经前烦躁障碍(PMDD)病理生理中的作用。PubMed检索相关文献发现,别孕烯醇酮等GABAA受体正向变构调节剂在易感个体中可能诱发PMDD症状,目前尚无有效治疗。

要点

  • 别孕烯醇酮等GABAA受体调节剂在高浓度时镇静,低浓度时可致焦虑易怒,存在个体敏感性差异。
  • PMDD患者与健康对照者脑功能及GABAA受体亚组成存在与别孕烯醇酮水平相关的差异。
  • 抑制排卵有效但副作用严重,需补充激素,而补充激素可能诱发不良情绪。

核心结论

  • 目前尚无有效治疗PMDD的方法。
  • 别孕烯醇酮似乎是易感个体中PMDD症状的关键诱发因素。

研究设计与样本

  • PubMed检索包含Premenstrual syndrome AND neurosteroids OR allopregnanolone OR GABA OR oestradiol的文献,并补充作者已知文献及动物研究。

主要发现

  • 别孕烯醇酮等GABAA受体正向变构调节剂在高浓度时镇静,在少数人中低浓度时引起焦虑和易怒,提示个体敏感性差异。
  • 比较PMDD女性与健康对照的研究发现,脑功能和GABAA受体亚组成存在与别孕烯醇酮水平相关的差异。
  • 神经活性类固醇水平的波动似乎总体加重症状。
  • 抑制排卵有效,但需补充激素以防止严重副作用,而补充激素可能在这些个体中引起不良情绪。

临床怎么用

  • 未来研究应聚焦于干扰神经甾体作用或GABAA受体本身可塑性的干预措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Premenstrual dysphoric disorder (PMDD) is common, with at least 3% of the female population affected by one or more of the typical mood symptoms of depression, irritability, mood swings and anxiety. The cyclicity and close relationship to the luteal phase of the menstrual cycle is characteristic for this syndrome and positive allosteric modulators (PAMs) on the GABAA receptor, especially allopregnanolone, are believed to be involved in the symptomatology. AIM: To summarise the research on the role of PAMs and other neuroactive steroids in the pathophysiology of PMDD. METHOD: PubMed was searched for articles including the terms Premenstrual syndrome, AND neurosteroids OR allopregnanolone OR GABA OR oestradiol. Many additional publications were previously known to the authors and basic animal research was covered in a secondary step through reference lists. RESULTS: There is evidence that allopregnanolone, like other PAMs of the GABAA receptor, is sedative in high concentrations and, in a minor proportion of the population, causes anxiety and irritability at lower levels, pointing to an inter-individual difference in sensitivity. In research comparing women with PMDD and healthy controls, differences in brain function and subcomposition of GABAA receptors related to levels of allopregnanolone have been found. Also, the varying levels of neuroactive steroids in general seem to worsen the symptoms. Supressed ovulation is effective but add-back hormones are necessary to prevent severe side-effects and could cause adverse mood in these individuals. CONCLUSIONS: There is yet no effective treatment for PMDD available. Allopregnanolone seems to be a key provocateur of PMDD symptoms in susceptible individuals. Future research should focus on interventions that interfere with the effects of neurosteroids or the plasticity of the GABAA receptor itself.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Bixo M, Stiernman L, Bäckström T, et al. Neurosteroids and premenstrual dysphoric disorder. Br J Psychiatry. 2025. PMID: 40518728. doi:10.1192/bjp.2025.103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。